FORT LAUDERDALE, Fla. — Suprachoroidal drug delivery is a novel approach that targets posterior tissues, minimizes exposures to the anterior segment and has shown benefits as a diabetic macular edema treatment in early studies, a speaker said here.
“The medication is delivered to the sclera-choroid. It has the potential to reduce cataract formation and incidence of high IOP spikes, as it delivers the drug in great concentrations to the retina and less to the anterior chamber,” Mark R. Barakat, MD, said at the Retina World Congress.
Early studies have shown (Read more...)
Uncategorized